Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| WARD-HOME feasibility | Other Identifier | Bispebjerg Hospital |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Rigshospitalet, Denmark | OTHER |
| Technical University of Denmark | OTHER |
Not provided
Not provided
Not provided
Not provided
The current study aims to investigate the feasibility of transmitting continuous and wireless vital sign data in real time from patients home to the hospital in patients discharged after an acute medical hospitalization
The healthcare system is challenged by an aging patient population with chronic diseases, and acute admissions must be housed in hospitals with fewer beds and less staff resources. This increases the need for earlier discharge and for treatment shifted to the patients' own home. Furthermore, the transition from the hospital to the home setting is one of potential hazard, due to the lack of observation and intervention possibilities.
This study aims to investigate the feasibility of wireless, continuous monitoring of patients in the days around discharge after an acute medical hospitalization, as well as occurrence of deviating vital signs i in the patients' own homes during the first days after discharge. Data will be transmitted continuously in real time from patient's homes to mobile applications for portable handheld devices such as healthcare personnel's smartphones.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Observed patients | Adult patients (≥18 years) admitted with an acute medical disease and who are scheduled for discharge to their own homes within five days from inclusion. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Wireless and continuously monitoring | Device | Included patients are monitored with WARD equipment during the last part of hospitalization and the first days after discharge with data transmitted in real time to personnel at the hospital. Monitoring will last for a maximum of 72 hours. |
| Measure | Description | Time Frame |
|---|---|---|
| Duration of data collection from the Lifetouch patch | Up to 72 hours of monitoring |
| Measure | Description | Time Frame |
|---|---|---|
| Duration of complete peripheral saturation data | Up to 72 hours of monitoring | |
| Duration of complete blood pressure data | Up to 72 hours of monitoring | |
| Cummulated duration of desaturation |
| Measure | Description | Time Frame |
|---|---|---|
| Re-admission and cause of re-admission within 30-days | 30-days follow up | |
| User experiences (patient and personnel) | Within 72 hours of monitoring |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients admitted with an acute medical disease at Bispebjerg Hospital and scheduled for discharge to their own homes within five days from inclusion.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Emilie Sigvardt, MD | Bispebjerg Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Bispebjerg Hospital | Copenhagen | NV | 2400 | Denmark |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000075902 | Clinical Deterioration |
| D018450 | Disease Progression |
| D020969 | Disease Attributes |
| ID | Term |
|---|---|
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
|
Peripheral saturation below 88% and 85% |
| Up to 72 hours of monitoring |
| Number of events with SpO2 < 88% in at least 10 consecutive minutes | Up to 72 hours of monitoring |
| Number of events with SpO2 < 85% in at least 5 consecutive minutes | Up to 72 hours of monitoring |
| Number of deviating vital parameters in accordance to defined microevents | Up to 72 hours of monitoring |